文献速递心脑血管急症重症综合管理与镇静镇痛

急性心肌梗死患者微粒促凝特征研究

[Study on the procoagulant characteristics of microparticles in acute myocardial infarction].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2024-01-01
一句话结论急性心肌梗死患者循环TF+MP水平显著高于非AMI冠心病患者,且与DIC评分、D-二聚体、FDP正相关,与外源性通路因子FⅦ及共同通路因子FⅩ负相关。

该研究为前瞻性病例对照研究,纳入2023年6月至11月哈尔滨市第一医院心内二科收治的52例冠心病患者,按是否发生AMI分为AMI组26例和非AMI组26例。入院当天计算DIC评分并检测D-二聚体、FDP、主要凝血因子活性及循环微粒水平。结果显示AMI组DIC评分、D-二聚体、FDP及TF+MP水平均显著高于非AMI组,多种凝血因子消耗更重;循环TF+MP与DIC评分、D-二聚体、FDP正相关,与FⅦ、FⅩ负相关。作者认为TF+MP可能通过激活外源性凝血途径、加重凝血因子消耗促进血栓形成。

要点

  • AMI组DIC评分3(3,4)vs非AMI组3(2,3),D-二聚体8.80(6.84,15.66)mg/L vs 2.13(1.64,3.86)mg/L,FDP 30.13(19.30,52.54)mg/L vs 20.00(13.51,28.37)mg/L,均P<0.01。
  • AMI组循环TF+MP 0.13(0.06,0.20)nmol/L显著高于非AMI组0.08(0.04,0.15)nmol/L,P<0.05;循环微粒总量两组无显著差异。
  • AMI组FⅡ、FⅤ、FⅦ、FⅩ、FⅪ、FⅫ活性均低于非AMI组(均P<0.05),提示凝血因子消耗更重。
  • 冠心病患者TF+MP与DIC评分(r=0.307,P=0.027)、D-二聚体(r=0.696,P<0.001)、FDP(r=0.582,P<0.001)正相关,与FⅦ(r=-0.521,P<0.001)、FⅩ(r=-0.332,P=0.016)负相关。
  • 作者认为TF+MP可能参与激活外源性凝血途径、加重凝血因子消耗并促进血栓形成。

适用人群与场景

  • 2023年6月至11月哈尔滨市第一医院心内二科收治的冠心病患者,按入院时是否发生AMI分为AMI组26例和非AMI组26例。
  • 两组性别、年龄、BMI、基础疾病、吸烟史及入院前治疗无显著差异,基线均衡可比。

研究设计与关键结果

  • 前瞻性病例对照研究,纳入52例冠心病患者(AMI组26例、非AMI组26例),入院当天计算DIC评分、检测D-二聚体、FDP、主要凝血因子活性,用微粒捕获法测循环微粒、组织因子依赖FⅩa生成试验测TF+MP。
  • AMI组DIC评分3(3,4)vs非AMI组3(2,3),D-二聚体8.80(6.84,15.66)mg/L vs 2.13(1.64,3.86)mg/L,FDP 30.13(19.30,52.54)mg/L vs 20.00(13.51,28.37)mg/L,均P<0.01。
  • 凝血因子活性AMI组vs非AMI组:FⅡ 59.45%(49.65%,71.25%)vs 63.65%(49.98%,73.22%),FⅤ 96.95%(73.50%,112.78%)vs 105.05%(73.48%,131.48%),FⅦ 42.30%(36.98%,51.98%)vs 53.40%(46.58%,69.88%),FⅩ 60.90%(48.22%,80.82%)vs 73.50%(56.80%,85.98%),FⅪ 82.45%(62.90%,99.10%)vs 92.40%(73.90%,114.25%),FⅫ 29.90%(12.42%,42.38%)vs 34.65%(16.32%,48.20%),均P<0.05。
  • AMI组循环TF+MP 0.13(0.06,0.20)nmol/L vs非AMI组0.08(0.04,0.15)nmol/L,P<0.05;循环微粒总量1.24(0.71,3.77)nmol/L vs 1.35(0.73,2.14)nmol/L,P>0.05。
  • 冠心病患者TF+MP与DIC评分(r=0.307,P=0.027)、D-二聚体(r=0.696,P<0.001)、FDP(r=0.582,P<0.001)正相关,与FⅦ(r=-0.521,P<0.001)、FⅩ(r=-0.332,P=0.016)负相关。

证据类型、等级与局限

  • 证据类型:前瞻性病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为TF+MP可能在AMI发生时激活外源性凝血途径、加重凝血因子消耗、促进血栓形成中起重要作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the characteristic of circulating microparticle in patients with acute myocardial infarction (AMI) and its possible mechanism of promoting coagulation.

METHODS: A prospective case-control study was conducted. The patients with coronary heart disease admitted to the second department of cardiology in Harbin First Hospital from June to November 2023 were enrolled, and they were grouped according to whether the patients occurred AMI or not. On the day of admission, disseminated intravascular coagulation (DIC) score was calculated. At the same time, fasting venous blood was collected, and the levels of D-dimer, fibrin degradation product (FDP) and the activities of major coagulation factors were detected. The level of circulating microparticle was determined by microparticle trapping method. The microparticle carrying tissue factor (TF+MP) level was detected by tissue factor (TF) dependent F Xa production assay. Spearman correlation method was used to analyze the correlation among the indicators.

RESULTS: A total of 52 patients with coronary heart disease were enrolled, including 26 patients in AMI group and 26 patients in non-AMI group. There was no significant difference in gender, age, body mass index (BMI), underlying diseases, smoking history, and pre-admission treatment of patients between the two groups, indicating that the baseline data of the two groups were balanced and comparable. Compared with the non-AMI group, the DIC score and D-dimer, FDP levels in the AMI group were significantly increased [DIC score: 3 (3, 4) vs. 3 (2, 3), D-dimer (mg/L): 8.80 (6.84, 15.66) vs. 2.13 (1.64, 3.86), FDP (mg/L): 30.13 (19.30, 52.54) vs. 20.00 (13.51, 28.37), all P < 0.01], indicating that the degree of coagulation activation in AMI patients was more severe. The consumption of major coagulation factors in the coagulation pathway in the AMI group was heavier than that in the non-AMI group [F II: 59.45% (49.65%, 71.25%) vs. 63.65% (49.98%, 73.22%), F V: 96.95% (73.50%, 112.78%) vs. 105.05% (73.48%, 131.48%), F VII: 42.30% (36.98%, 51.98%) vs. 53.40% (46.58%, 69.88%), F X: 60.90% (48.22%, 80.82%) vs. 73.50% (56.80%, 85.98%), F XI: 82.45% (62.90%, 99.10%) vs. 92.40% (73.90%, 114.25%), F XII: 29.90% (12.42%, 42.38%) vs. 34.65% (16.32%, 48.20%), all P < 0.05]. The circulating TF+MP level in the AMI group was significantly higher than that in the non-AMI group [nmol/L: 0.13 (0.06, 0.20) vs. 0.08 (0.04, 0.15), P < 0.05]. There was no significant difference in the level of circulating microparticle between AMI group and non-AMI group [nmol/L: 1.24 (0.71, 3.77) vs. 1.35 (0.73, 2.14), P > 0.05]. Correlation analysis showed that circulating TF+MP level in the patients with coronary heart disease was significantly positively correlated with coagulation indicator DIC score (r = 0.307, P = 0.027), D-dimer (r = 0.696, P < 0.001) and FDP (r = 0.582, P < 0.001), and there was a strong negative correlation with exogenous pathway factor F VII (r = -0.521, P < 0.001) and common pathway factor F X (r = -0.332, P = 0.016).

CONCLUSIONS: The circulating TF+MP level in AMI patients was significantly higher than that in the non-AMI patients. TF+MP may play an important role in activating the extrinsic coagulation pathway, exacerbating coagulation factor consumption, and promoting clot formation during AMI occurrence.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu B, Meng S. [Study on the procoagulant characteristics of microparticles in acute myocardial infarction]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39223887. doi:10.3760/cma.j.cn121430-20231218-01092

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。